FR2327798A1 - Agents de diagnostic du cancer - Google Patents

Agents de diagnostic du cancer

Info

Publication number
FR2327798A1
FR2327798A1 FR7531942A FR7531942A FR2327798A1 FR 2327798 A1 FR2327798 A1 FR 2327798A1 FR 7531942 A FR7531942 A FR 7531942A FR 7531942 A FR7531942 A FR 7531942A FR 2327798 A1 FR2327798 A1 FR 2327798A1
Authority
FR
France
Prior art keywords
products
proteins
malignin
target
recognins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7531942A
Other languages
English (en)
Other versions
FR2327798B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2327798A1 publication Critical patent/FR2327798A1/fr
Application granted granted Critical
Publication of FR2327798B1 publication Critical patent/FR2327798B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7531942A 1975-02-18 1975-10-17 Agents de diagnostic du cancer Granted FR2327798A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55043275A 1975-02-18 1975-02-18
US55307575A 1975-02-25 1975-02-25

Publications (2)

Publication Number Publication Date
FR2327798A1 true FR2327798A1 (fr) 1977-05-13
FR2327798B1 FR2327798B1 (fr) 1979-04-13

Family

ID=27069453

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531942A Granted FR2327798A1 (fr) 1975-02-18 1975-10-17 Agents de diagnostic du cancer

Country Status (1)

Country Link
FR (1) FR2327798A1 (fr)

Also Published As

Publication number Publication date
FR2327798B1 (fr) 1979-04-13

Similar Documents

Publication Publication Date Title
JF The purification of aconitase.
Boss et al. Abelson virus-transformed haematopoietic cell lines with pre-B-cell characteristics
ATE130873T1 (de) Nachweis der expression von neu genen und produkten.
GB1303408A (fr)
Paul et al. Stimulation of DNA and protein synthesis in fetal-rat liver cells by serum from partially hepatectomized rats
ES398962A1 (es) Un procedimiento para la preparacion de una composicion de enzima.
HUT61202A (en) Process for producing pharmaceutical compositions neutralizing procoagulant activity caused by tumour cells
Kahn et al. Gd (-) Abrami a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis
Blair et al. Serum factors in mammary neoplasia: Enhancement and antagonism of spleen cell activity in vitro detected by different methods of serum factor assay
ES8206855A1 (es) Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.
Rosa et al. Different heterogeneities of mouse haemoglobin according to strains
FR2327798A1 (fr) Agents de diagnostic du cancer
Catch et al. Purification and chemistry of penicillin
Gottlieb et al. Enzymatic decomposition of lignin
Freinkel et al. The synthesis of mesoinositol in germ-free rats and mice
Ada et al. Effect of haemagglutinating viruses on the electrophoretic mobility of human erythrocytes
GB1443948A (en) Production of immunological material
EP0282018A3 (en) Process for isolating basal membrane proteins from human or animal tissues
Merler et al. Absence of endotoxic activity in materials derived without bacterial contamination from mammalian tissue
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
KOSAKI et al. FURTHER STUDIES ON A MITOSIS PROMOTING SUBSTANCE (ONCOTREPHIN) IN HUMAN MALIGNANT TUMORS ITS EFFECT ON STRAIN L CELLS
van Zant et al. Study of haemopoietic microenvironment in vitro
SU578322A1 (ru) Водный раствор дл химического полировани нержавеющей стали
GB1525451A (en) Method for processing activated sludge into useful products
GB1378103A (en) Serological reagent and test for neisseria gonorrhoeae antibodies

Legal Events

Date Code Title Description
ST Notification of lapse
R1 Appeal
DS Decision of the director general to state about an appeal
ST Notification of lapse